http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200800181-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 |
| filingDate | 2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb5939f5efde17c591af4f93091e05d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d2a49bc6c8f0e86b39e38b7b84cabe9 |
| publicationDate | 2008-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-200800181-A |
| titleOfInvention | Pharmaceutical composition for anticancer |
| abstract | The present invention provides to an antitumor pharmaceutical composition for preventing or treating carcinoma, sarcoma or hematopoietic tumor. The present invention relates an antitumor pharmaceutical composition for preventing or treating carcinoma, sarcoma or hematopoietic tumor, which consists, as the active component, a compound of the following formula(I) : [wherein, R represents a halogen atom; a hydroxy group; a C1-C6 alkyl group; a halogeno C1-C6 alkyl group; a C1-C6 alkoxyl group; a C1-c6 alkylthio group; an optionally substituted amino group; an optionally substituted C3-C10 cycloarkyl, C6-C10 aryl, C7-C16 aralkyl, C6-C10 aryloxy, C7-C16 aralkyloxy and C6-C10 arylthio; an C1-C7 aliphatic acyloxy group; a N-containing 4-7 membered saturated heterocyclic group; a N-containing 5-6 membered aromatic heterocyclic group; a nitro group; and a phenyl group optionally substituted with 1-5 groups selected from a cyano group, X represents a oxygen atom or a sulfur atom], or the pharmaceutically acceptable salt thereof, and an antitumor pharmaceutical composition for preventing or treating carcinoma, sarcoma or hematopoietic tumor, which consists, as the active component, an epidermis growth factor reseptor(EGFR) inhibitor, a vascular endothelial cell growth factor reseptor(VEGFR) inhibitor or a Raf kinase inhibitor, and a compound of the above formula(I) or the pharmaceutically acceptable salt thereof, these are administrated simultaneously or separatly in time. |
| priorityDate | 2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 246.